![](/img/cover-not-exists.png)
RVX-208 THE FIRST SELECTIVE BROMODOMAIN EXTRA-TERMINAL PROTEIN INHIBITOR BEING DEVELOPED FOR PATIENTS WITH HIGH RESIDUAL RISKS OF CARDIOVASCULAR DISEASE
Wong, Norman Cw, Johansson, Jan, Lebioda, Kenneth, Halliday, Christopher, Kulikowski, EwelinaVolume:
65
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(15)60258-3
Date:
March, 2015
File:
PDF, 287 KB
english, 2015